These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8201528)

  • 1. Ex-vivo and in-vivo antithrombotic effect of triflavin, an RGD-containing peptide.
    Sheu JR; Huang TF
    J Pharm Pharmacol; 1994 Jan; 46(1):58-62. PubMed ID: 8201528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice.
    Sheu JR; Chao SH; Yen MH; Huang TF
    Thromb Haemost; 1994 Oct; 72(4):617-21. PubMed ID: 7878641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
    Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
    Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.
    Huang TF; Sheu JR; Teng CM
    Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):351-7. PubMed ID: 1859363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triflavin, an Arg-Gly-Asp-containing peptide, prevents platelet plug formation in in vivo experiments.
    Sheu JR; Yen MH; Peng HC; Chang MC; Huang TF
    Eur J Pharmacol; 1995 Dec; 294(1):231-8. PubMed ID: 8788436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
    Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
    J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
    Huang TF; Liu CZ; Ouyang CH; Teng CM
    Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of a potent antiplatelet peptide, triflavin from Trimeresurus flavoviridis snake venom.
    Huang TF; Sheu JR; Teng CM
    Thromb Haemost; 1991 Oct; 66(4):489-93. PubMed ID: 1665595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triflavin, an Arg-Gly-Asp-containing antiplatelet peptide inhibits cell-substratum adhesion and melanoma cell-induced lung colonization.
    Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
    Jpn J Cancer Res; 1992 Aug; 83(8):885-93. PubMed ID: 1399825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triflavin, an RGD-containing antiplatelet peptide, binds to GpIIIa of ADP-stimulated platelets.
    Sheu JR; Teng CM; Huang TF
    Biochem Biophys Res Commun; 1992 Dec; 189(2):1236-42. PubMed ID: 1472031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triflavin inhibits platelet-induced vasoconstriction in de-endothelialized aorta.
    Sheu JR; Yen MH; Hung WC; Lee YM; Su CH; Huang TF
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3461-8. PubMed ID: 9437193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
    Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S
    J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
    Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
    Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
    Teng CM; Wu CC; Ko FN; Lee FY; Kuo SC
    Eur J Pharmacol; 1997 Feb; 320(2-3):161-6. PubMed ID: 9059849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom.
    Huang TF; Wang WJ; Teng CM; Ouyang C
    Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
    Rahman S; Lu X; Kakkar VV; Authi KS
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits tumor cell-induced platelet aggregation.
    Sheu JR; Lin CH; Peng HC; Teng CM; Huang TF
    Jpn J Cancer Res; 1993 Oct; 84(10):1062-71. PubMed ID: 8226281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the binding character of triflavin on resting and activated alpha(IIb)beta(3) integrin in human platelets by electron microscopy.
    Chuang WJ; Wu CH; Huang HN; Chen SH; Hsiao G; Lin CH; Sheu JR
    Thromb Res; 2003 Jan; 109(1):37-46. PubMed ID: 12679130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the disintegrin, triflavin, in a rat middle cerebral artery thrombosis model.
    Kaku S; Umemura K; Mizuno A; Kawasaki T; Nakashima M
    Eur J Pharmacol; 1997 Mar; 321(3):301-5. PubMed ID: 9085041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.